Hymenolepis infection medical therapy: Difference between revisions
No edit summary |
m Changes made per Mahshid's request |
||
| (6 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hymenolepis infection}} | {{Hymenolepis infection}} | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Overview== | |||
A prescription drug called [[praziquantel]] is given. The medication causes the tapeworm to dissolve within the intestines. Praziquantel is generally well tolerated. Sometimes more than one treatment is necessary. | |||
==Medical Therapy== | ==Medical Therapy== | ||
A | |||
===Pharmacotherapy=== | |||
====Acute Pharmacotherapies==== | |||
[[Praziquantel]] as a single dose (25 mg/kg) is the current treatment of choice for hymenolepiasis and has an efficacy of 96%. Single dose [[albendazole]] (400 mg) is also very efficacious (>95%). [[Niclosamide]] has also been used. | |||
A three-day course of [[nitazoxanide]] is 75–93% efficacious. The dose is 1g daily for adults and children over 12; 400mg daily for children aged 4 to 11 years; and 200mg daily for children aged 3 years or younger.<ref>{{cite journal | author=Ortiz JJ, Favennec L, Chegne NL, Gargala G. | year=2002 | title=Comparative clinical studis of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis, and hymenolepiasis in children from Peru | journal=Trans R Soc Trop med Hyg | volume=96 | pages=193–96 | id=PMID 12055813 }}</ref><ref>{{cite journal | author=Reomero-Cabello R, Guerro LR, Munez-Gracia MR, Geyne Cruz A. | year=1997 |title=Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in México. | journal=Trans R Soc Trop Med Hyg | volume=91 | pages=701–3 }}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category: | [[Category:Parasitic diseases]] | ||
Latest revision as of 18:04, 18 September 2017
|
Hymenolepis infection Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hymenolepis infection medical therapy On the Web |
|
American Roentgen Ray Society Images of Hymenolepis infection medical therapy |
|
Risk calculators and risk factors for Hymenolepis infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
A prescription drug called praziquantel is given. The medication causes the tapeworm to dissolve within the intestines. Praziquantel is generally well tolerated. Sometimes more than one treatment is necessary.
Medical Therapy
Pharmacotherapy
Acute Pharmacotherapies
Praziquantel as a single dose (25 mg/kg) is the current treatment of choice for hymenolepiasis and has an efficacy of 96%. Single dose albendazole (400 mg) is also very efficacious (>95%). Niclosamide has also been used.
A three-day course of nitazoxanide is 75–93% efficacious. The dose is 1g daily for adults and children over 12; 400mg daily for children aged 4 to 11 years; and 200mg daily for children aged 3 years or younger.[1][2]
References
- ↑ Ortiz JJ, Favennec L, Chegne NL, Gargala G. (2002). "Comparative clinical studis of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis, and hymenolepiasis in children from Peru". Trans R Soc Trop med Hyg. 96: 193&ndash, 96. PMID 12055813.
- ↑ Reomero-Cabello R, Guerro LR, Munez-Gracia MR, Geyne Cruz A. (1997). "Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in México". Trans R Soc Trop Med Hyg. 91: 701&ndash, 3.